June 07, 2010 Media contact: Nicole Fawcett
E-mail: nfawcett@umich.edu
Phone: 734-764-2220

Genetic markers could predict prostate cancer in younger men, study finds

Researchers link panel of genes to early onset prostate cancer

Meet the expert:
Kathleen Cooney, M.D.

Learn more:
U-M Comprehensive Cancer Center

Read the report

ANN ARBOR, Mich. — Prostate cancer has become more common in younger men, and it’s often more aggressive in these men. A new study from researchers at the University of Michigan Comprehensive Cancer Center has found that a series of genetic mutations could help detect this early onset prostate cancer.

Researchers believe that genetics and traditional screening methods could play a role in predicting the risk of prostate cancer in younger men.
 
“This is a potential opportunity to combine PSA testing with genetic markers to determine who has significant prostate cancer. It could be a combination of age and family history that could help us determine who should be tested with PSA and a panel of genetic markers,” says study author Kathleen Cooney, M.D., Frances and Victor Ginsberg Professor of Hematology/Oncology and division chief of hematology/oncology at the U-M Medical School.
 
Researchers looked for 14 different gene mutations in 754 men age 56 and younger with prostate cancer. The men were enrolled in the Prostate Cancer Genetics Project at U-M. Researchers also looked at 1,163 older men with prostate cancer and 2,713 men without prostate cancer.
 
The study, which was presented at the American Society of Clinical Oncology annual meeting, found that the younger men carried more of these genetic mutations. In addition, 30 percent of the younger men had aggressive prostate cancer and 41 percent of these men had at least one first-degree relative with prostate cancer.
 
“Early onset prostate cancer has a strong genetic component, which we saw in this study. The genetic variants we looked at here are likely not the best indicators. Our next step is to look more widely for common genetic variants among this group of men,” Cooney says.
 
The researchers continue to enroll men in this study. They will next look at the genome of a larger population of men with early onset prostate cancer to find common mutations that may be linked to the disease. For information, call the U-M Cancer AnswerLine at 800-865-1125.
 
Prostate cancer statistics: 192,280 Americans will be diagnosed with prostate cancer this year and 27,360 will die from the disease, according to the American Cancer Society
 
Additional authors: Claudia Salinas, Anna Ray, and Kimberly Zuhlke, from U-M; Yunfei Wang and Ethan Lange from University of North Carolina at Chapel Hill
 
Funding: Prostate Cancer Specialized Program of Research Excellence, National Cancer Institute, U-M Cancer Center
 
Reference: American Society of Clinical Oncology Annual Meeting, June 4-8, 2010, Chicago, Abstract No. 4502
 
Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center
Clinical trials at U-M